EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Succinate coenzyme A ligase β‐like protein from Trichinella spiralis is a potential therapeutic molecule for allergic asthma

Kalibixiati Aimulajiang, Wen Chu, Shuyi Liao, Zhaohai Wen, Rongdong He, Mingmin Lu, Lixin Xu, Xiaokai Song, Xiangrui Li, Ruofeng Yan iD

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Kalibixiati Aimulajiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Animal Health and Food Safety, MOE Joint International Research, College of Veterinary Medicine, Nanjing Agricultural University, Nanji…. Hauptthemen laut MEDLINE: Asthma, Helminth Proteins, Trichinella spiralis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund, Social Development Project of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

For decades, studies have demonstrated the anti‐inflammatory potential of proteins secreted by helminths in allergies and asthma. Previous studies have demonstrated the immunomodulatory capabilities of Succinate Coenzyme A ligase beta‐like protein (SUCLA‐β) derived from Trichinella spiralis , a crucial excretory product of this parasite.

Objective

To explore the therapeutic potential of SUCLA‐β in alleviating and controlling ovalbumin (OVA)‐induced allergic asthma, as well as its influence on host immune modulation.

Methods

In this research, we utilized the rTs‐SUCLA‐β protein derived from T. spiralis to investigate its potential in mitigating airway inflammation in a murine model of asthma induced by OVA sensitization/stimulation, both pre‐ and post‐challenge. The treatment's efficacy was assessed by quantifying the extent of inflammation in the lungs.

Results

Treatment with rTs‐SUCLA‐β demonstrated efficacy in ameliorating OVA‐induced airway inflammation, as evidenced by a reduction in eosinophil infiltration, levels of OVA‐specific Immunoglobulin E, interferon‐γ, interleukin (IL)‐9, and IL‐17A, along with an elevation in IL‐10. The equilibrium between Th17 and Treg cells plays a pivotal role in modulating the abundance of inflammatory cells within the organism, thereby ameliorating inflammation and alleviating symptoms associated with allergic asthma. Conclusions and Clinical Relevance Our data revealed that T. spiralis ‐derived Ts‐SUCLA‐β protein may inhibit the allergic airway inflammation by regulating host immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaHelminth ProteinsTrichinella spiralisAnimalsFemaleMiceCytokinesDisease Models, AnimalHypersensitivityImmunoglobulin ELungMice, Inbred BALB COvalbuminT-Lymphocytes, RegulatoryTh17 Cells

Stichwörter der Autor:innen

Succinate Coenzyme A ligase beta‐like proteinTrichinella spiralisallergic asthmahelminth moleculesimmune regulation

Substanzen

CytokinesHelminth ProteinsImmunoglobulin EOvalbumin

Autor:innen und Institutionen

  • Laboratory of Animal Health and Food Safety, MOE Joint International Research, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, Jiangsu, P. R. China.
  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Medicine Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P.…
  • Changsha Animal and Plant Disease Control Center, Changsha, Hunan, P. R. China.
  • Department of Veterinary Medicine, College of Coastal Agricultural Sciences, Guangdong Ocean University, Zhanjiang, P. R. China.

ORCID-Profile: Ruofeng Yan

Förderung

  • State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia Fund
  • Social Development Project of Jiangsu Province

Zitieren

APA

Aimulajiang, K., Chu, W., Liao, S., Wen, Z., He, R., Lu, M., Xu, L., Song, X., Li, X., & Yan, R. (2024). Succinate coenzyme A ligase β‐like protein from Trichinella spiralis is a potential therapeutic molecule for allergic asthma. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1321

Vancouver

Aimulajiang K, Chu W, Liao S, Wen Z, He R, Lu M, et al. Succinate coenzyme A ligase β‐like protein from Trichinella spiralis is a potential therapeutic molecule for allergic asthma. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1321

BibTeX
@article{Aimulajiang2024,
  author = {Aimulajiang, Kalibixiati and Chu, Wen and Liao, Shuyi and Wen, Zhaohai and He, Rongdong and Lu, Mingmin and Xu, Lixin and Song, Xiaokai and Li, Xiangrui and Yan, Ruofeng},
  title = {Succinate coenzyme A ligase β‐like protein from Trichinella spiralis is a potential therapeutic molecule for allergic asthma},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1321}
}
Kostenlos starten →